Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T65501 | ||||
Target Name | DNA [cytosine-5]-methyltransferase 3B (DNMT3B) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | (L-)-S-adenosyl-L-homocysteine | Drug Info | IC50 = 250 nM | [3] | |
(L-)-S-adenosyl-L-homocysteine | Drug Info | IC50 = 200 nM | [2] | ||
NSC-622445 | Drug Info | IC50 = 17000 nM | [3] | ||
S-tubercidinylhomocysteine | Drug Info | IC50 = 300 nM | [1] | ||
References | |||||
REF 1 | SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. Bioorg Med Chem Lett. 2009 May 15;19(10):2747-51. | ||||
REF 2 | Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. Bioorg Med Chem Lett. 2009 May 15;19(10):2742-6. | ||||
REF 3 | Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem. 2010 Jan 15;18(2):822-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.